Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

GSK plc (GSK)

London
Symbol
Exchange
Currency
GSKLondonGBP
GSKlBATS EuropeGBP
GSKNYSEUSD
GLAXFOTC MarketsUSD
GSKNMexicoMXN
GS70yFrankfurtEUR
GS71FrankfurtEUR
GS71TradeGateEUR
GS71XetraEUR
GSKBuenos AiresARS
Currency in GBP
Disclaimer
1,644.50
+8.50(+0.52%)
Real-time Data

GSK Price Commentary

what time are results out thanks
Wait for the result
Is it a best buy now or worth waiting? last couple of months high fluctuations in mid week and going up on Friday
Too much debt, will not go anywhere.
Hopefully this will go little bit more down in the next few day, to buy more. After this week probably will reverse, ex-date end of October.
£23.4B in debt and still paying bilions in dividends. Who thinks that is sustainable?
What are you on about? Debt to equity ratio has been reduced significantly in the last 3 years. Now at a healthier level around 1.3
The payout ratio is just 60%, you kidding me. (:
well lets looks in Aug last year when I made that comment it was 1750 now is 1250. looks like i do know what im talking about. :D
Have extended my holding while SP is below £16. A big well organised pharma while everyone is screwed up about their health looks to be a sound investment.
Will GlaxoSmithKline hit £20.00 this year ?
Having bought & sold this stock over the years & hold some currently, I think £18 is more realistic.
Uniphar Group PLC (UPR) undervalued pharmaceutical company!
Trap!
1707 & climbing up. Pharmaceuticals must be the most sensible area to invest in at the moment with CV19 doing a great hatchet job.
fast thinking GSK good buy
I have just sold Easyjet & bought GSK.
Uniphar Group (UPR) would have been a better buy!
The world has changed in favour of GSK. I remember 20 yrs ago we used to say buy under £18 & sell if over. I think £18-20 SP may well return this year with civilisation hanging on for a vaccine.
Glaxo is performing very well I have more hope in the long run
With the news of vaccine trials for CV19 starting tomorrow, there must some mileage in it for GSK despite not for profit comments. They are excellent at mass producing vaccines. Have been for years and now could be their moment. 1667 today.
the long term is the only way to predict
I think the CV vaccine will come under the heading' non-profit making' SP has come up from my last comment but don't think it will go sky-high.
A intresting time for GSK, they have two things that can swing the price either way. A drop in price due to de merger could a great oppurtunity for bulls as im sure they will be right at the forefront of the push for the vaccine. Lemme know your thoughts
My initial reaction was to buy in [which I did] on the principle that GSK have always been a great vaccine producer. However, I heard the the CEO saying quite rightly that the profits from CV vaccine would be ploughed back into research/good causes etc. I would imagine the company would not want to be seen as profiteering from the misery CV has caused so the shareholder benefits might not be as great as if they were developing a new antidepressant or analgesic.
Hi guys, bought at 1571, yes or no?
must buy this share as long term investment just bought them
I'm sure this share is a good investment today @1570. GSK has always been big in vaccines & the potential demand is enormous with CV19. Also developing an effective therapeutic agent raises possibilities.
new 52 week lo in 5days
ready to big dowen move
This company should be going up with prospects of making a vaccine for corona virus, not heading down with demerger news.
Hi
hi
I have been a medic for years & have great confidence in the way GSK conduct their business. I'm sure they will make a comeback given time to higher SPs they reached in the past
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.